Showing 1121-1130 of 2048 results for "".
- KeraFactor Launches Dual-Wavelength Laser Cap for At-Home Hair Rejuvenationhttps://modernaesthetics.com/news/kerafactor-launches-dual-wavelength-laser-cap-for-at-home-hair-rejuvenation/2475388/KeraFactor recently announced the release of the KeraFlex Duo, a dual-wavelength laser cap designed to support at-home hair rejuvenation by targeting multiple levels of the scalp, according to a press announcement from the manufacturer. The device expands on the company’s earlie
- Aesthetic Management Partners Launches New Non-Surgical Skin Revitalization Systemhttps://modernaesthetics.com/news/aesthetic-management-partners-launches-new-non-surgical-skin-revitalization-system/2475387/Aesthetic Management Partners announced the launch of PLADUOpro, a dual argon and nitrogen gas plasma system designed for advanced skin restoration, earlier this month. The PLADUOpro was developed from more than two decades of research and according to a press release. Launched
- Galderma Establishes new US Headquarters in Florida to Strengthen Regional Leadershiphttps://modernaesthetics.com/news/galderma-establishes-new-us-headquarters-in-florida-to-strengthen-regional-leadership/2475385/Galderma announced Tuesday the company is establishing a new US headquarters in Miami, Florida. The new location aims to position Galderma at the heart of a thriving market for Dermatological Skincare and Injectable Aesthetics. The headquarter will be in the Brickell neighborhood and the
- Hydrafacial’s New HydraFillic with Pep9 Booster Targets Fine Line, Wrinkleshttps://modernaesthetics.com/news/hydrafacials-new-hydrafillic-with-pep9-booster-targets-fine-line-wrinkles/2475381/The Hydrafacial Company this week announced its latest innovation, the Hydrafacial HydraFillic with Pep9TM Booster. The HydraFillic with Pep9TM Booster is Hydrafacial’s first peptide-powered booster, formulated with a new proprietary complex of 9 peptides. It’s clinically pr
- AB Chopra Epigenetics Launches With Plan to Revolutionize Longevityhttps://modernaesthetics.com/news/ab-chopra-epigenetics-launches-with-plan-to-revolutionize-longevity/2475380/Charles Rosier, co-founder of the Augustinus Bader skincare and biotech company, and Deepak Chopra, MD, announced the launch of AB Chopra Epigenetics, a revolutionary longevity platform that merges advanced artificial intelligence, epigenetic science, and consciousness-based healing to redefine t
- Dr. Sebastian Cotofana Shares Unpublished Research Targeting Glabellar Lines with Neurotoxins at SCALEhttps://modernaesthetics.com/news/dr-sebastian-cotofana-shares-unpublished-research-targeting-glabellar-lines-with-neurotoxins-at-scale/2475377/The 20th anniversary of Music City Symposium for Cosmetic Advances and Laser Education (SCALE) was held from May 14 to 18 at the Grand Hyatt in Nashville, Tennessee. The agenda included an update on neurotoxin related to facial anatomy for improved aesthetic outcomes from Seb
- New Collaboration Enhances Precision and Patient Engagement in Post-Weight-Loss Treatmentshttps://modernaesthetics.com/news/new-collaboration-enhances-precision-and-patient-engagement-in-post-weight-loss-treatments/2475376/MNML Aesthetics announced a partnership with ShapeScale to integrate 3D body imaging into its MNML Tone Method, a multi-modality body contouring protocol. The collaboration aims to enhance clinical precision and patient engagement in aesthetic practices, particularly in post-weight-loss body tran
- Analysis: PBoNT/A and ABoNT/A Show Fastest Onset in Glabellar Line Treatmenthttps://modernaesthetics.com/news/analysis-pbonta-and-abonta-show-fastest-onset-in-glabellar-line-treatment/2475374/A newly published study reports the comparative effects of four botulinum toxin A (BoNT/A) formulations on glabellar strain, with observed differences in onset, longevity, and muscular strain patterns. Researchers pu
- FDA Panel Urges Removal of Talc from Consumer Products Due to Cancer Linkhttps://modernaesthetics.com/news/fda-panel-urges-removal-of-talc-from-consumer-products-due-to-cancer-link/2475371/A U.S. Food and Drug Administration (FDA) advisory panel has reinforced longstanding concerns over the carcinogenic potential of talc, urging the agency to restrict its use in foods, drugs, and cosmetics. Citing more
- Chinese Biotechnology Company Unveils Landmark Regenerative Aesthetic Medicine Innovationhttps://modernaesthetics.com/news/chinese-biotechnology-company-unveils-landmark-regenerative-aesthetic-medicine-innovation/2475368/Shanghai Moyom Biotechnology Co., Ltd. Announced the introduction of its new regenerative aesthetic product, Aphranel MagiCCrystal CaHA Filler, at an international event held at the Grand Halls on Shanghai’s Bund Themed “APHRANEL: Code Breaker, World Maker.” Aphranel MagiCCrystal CaHA Fil